IL-10Rα expression is post-transcriptionally regulated by miR-15a, miR-185, and miR-211 in melanoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1755-8794
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
IL-10Rα expression is post-transcriptionally regulated by miR-15a, miR-185, and miR-211 in melanoma ; volume:8 ; number:1 ; day:3 ; month:12 ; year:2015 ; pages:1-9 ; date:12.2015
BMC medical genomics ; 8, Heft 1 (3.12.2015), 1-9, 12.2015
- Creator
-
Venza, Isabella
Visalli, Maria
Beninati, Concetta
Benfatto, Salvatore
Teti, Diana
Venza, Mario
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12920-015-0156-3
- URN
-
urn:nbn:de:101:1-2019063021314021405928
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Venza, Isabella
- Visalli, Maria
- Beninati, Concetta
- Benfatto, Salvatore
- Teti, Diana
- Venza, Mario
- SpringerLink (Online service)
Other Objects (12)
Dysregulation of miR-15a and miR-214 in human pancreatic cancer
Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer
Down-regulated miR-9 and miR-433 in human gastric carcinoma
miR
MiR
Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
MicroRNAs miR-19, miR-340, miR-374 and miR-542 regulate MID1 protein expression
Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential
Zu MiR
Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma
Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers
Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms
Dysregulation of miR-15a and miR-214 in human pancreatic cancer
Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer
Down-regulated miR-9 and miR-433 in human gastric carcinoma
miR
MiR
Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
MicroRNAs miR-19, miR-340, miR-374 and miR-542 regulate MID1 protein expression
Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential
Zu MiR
Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma
Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers
Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms
Dysregulation of miR-15a and miR-214 in human pancreatic cancer
Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer
Down-regulated miR-9 and miR-433 in human gastric carcinoma
miR
MiR
Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
MicroRNAs miR-19, miR-340, miR-374 and miR-542 regulate MID1 protein expression
Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential
Zu MiR
Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma
Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers